Clinical Trial Update: A Study to Investigate Lung Deposition of Radiolabelled OligoG [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the lung deposition of radiolabelled OligoG in cystic fibrosis patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• OligoG (oligoG)

Snippet

Sponsor: BDD Pharma Ltd | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED